4//SEC Filing
McLaughlin Gerald W. 4
Accession 0001104659-20-034240
CIK 0001467652other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 6:56 PM ET
Size
8.0 KB
Accession
0001104659-20-034240
Insider Transaction Report
Form 4
McLaughlin Gerald W.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-03-13+100,000→ 100,000 totalExercise: $5.55Exp: 2028-07-30→ Common Stock (100,000 underlying) - Award
Stock Option (Right to Buy)
2020-03-13+65,447→ 65,447 totalExercise: $2.31Exp: 2029-03-01→ Common Stock (65,447 underlying)
Footnotes (2)
- [F1]On July 30, 2018, the reporting person was granted performance based options to purchase 200,000 shares of common stock. The option was subject to vesting upon the satisfaction of certain performance criteria, which were met with respect to 100,000 shares and were not met with respect to 100,000 shares, in each case as of March 13, 2020
- [F2]On March 1, 2019, the reporting person was granted performance based options to purchase 130,895 shares of common stock. The option was subject to vesting upon the satisfaction of certain performance criteria, which were met with respect to 65,447 shares and were not met with respect to 65,448 shares, in each case as of March 13, 2020.
Documents
Issuer
Neos Therapeutics, Inc.
CIK 0001467652
Entity typeother
Related Parties
1- filerCIK 0001495412
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 6:56 PM ET
- Size
- 8.0 KB